High-resolution integrated map encompassing the breast cancer loss of heterozygosity region on human chromosome 16q22.1

被引:15
作者
Frengen, E
Rocca-Serra, P
Shaposhnikov, S
Taine, L
Thorsen, J
Bepoldin, C
Krekling, M
Lafon, D
Aas, KK
Abd El Monéim, A
Johansen, H
Longy, M
Prydz, H
Dorion-Bonnet, F
机构
[1] Univ Oslo, Biotechnol Ctr Oslo, N-0349 Oslo, Norway
[2] Inst Bergonie, Lab Genet Mol EA515, Bordeaux, France
[3] Ctr Hosp Univ Pellegrin, Genet Lab, Bordeaux, France
关键词
D O I
10.1006/geno.2000.6389
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Loss of heterozygosity (LOH) on the long arm of human chromosome 16 is a common genetic alteration observed in both invasive ductal and invasive lobular breast carcinomas. We have generated a high resolution integrated map encompassing the smallest region of LOH overlap within chromosome 16q22.1 (SRO2). Southern hybridization experiments using more than 140 probes resulted in the assembly of 152 bacterial large-insert clones into a 2.8-Mb contig covering SRO2. The structure of the contig was verified by long-range mapping using total human genomic DNA, and the contig orientation was determined by fluorescence in situ hybridization. A total of 68 transcripts have been identified in the map. One of the genes residing within SRO2 is the E-cadherin gene, CDH1, which has previously been shown to be mutated in lobular breast carcinomas, resulting in loss of E-cadherin expression. In most cases of ductal carcinoma, which is the major mammary cancer type, E-cadherin is normally expressed, suggesting that other genes within 16q22.1 are involved in the development of this tumor subtype. The high-resolution map presented in this study provides a valuable resource for identification of tumor suppressor genes expected to be involved in the etiology of breast carcinomas. (C) 2000 Academic Press.
引用
收藏
页码:273 / 285
页数:13
相关论文
共 58 条
[31]   Ksp-cadherin gene promoter. II. Kidney-specific activity in transgenic mice [J].
Igarashi, P ;
Shashikant, CS ;
Thomson, RB ;
Whyte, DA ;
Liu-Chen, SX ;
Ruddle, FH ;
Aronson, PS .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1999, 277 (04) :F599-F610
[32]  
IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84
[33]   EPITHELIAL-CADHERIN GENE IS NOT MUTATED IN DUCTAL CARCINOMAS OF THE BREAST [J].
KASHIWABA, M ;
TAMURA, G ;
SUZUKI, Y ;
MAESAWA, C ;
OGASAWARA, S ;
SAKATA, K ;
SATODATE, R .
JAPANESE JOURNAL OF CANCER RESEARCH, 1995, 86 (11) :1054-1059
[34]   USING FLUORESCENCE INSITU HYBRIDIZATION (FISH) IN GENOME MAPPING [J].
KORENBERG, JR ;
YANGFENG, T ;
SCHRECK, R ;
CHEN, XN .
TRENDS IN BIOTECHNOLOGY, 1992, 10 (1-2) :27-32
[35]   CHOICE OF ENZYMES FOR MAPPING BASED ON CPG ISLANDS IN THE HUMAN GENOME [J].
LARSEN, F ;
GUNDERSEN, G ;
PRYDZ, H .
GENETIC ANALYSIS-BIOMOLECULAR ENGINEERING, 1992, 9 (03) :80-85
[36]   GENOMIC ALTERATIONS IN HUMAN BREAST CARCINOMAS [J].
LARSSON, C ;
BYSTROM, C ;
SKOOG, L ;
ROTSTEIN, S ;
NORDENSKJOLD, M .
GENES CHROMOSOMES & CANCER, 1990, 2 (03) :191-197
[37]  
Larsson L, 1993, APPL IMMUNOHISTO M M, V1, P2
[38]  
Latil A, 1997, CANCER RES, V57, P1058
[39]   Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex [J].
Le Cam, L ;
Polanowska, J ;
Fabbrizio, E ;
Olivier, M ;
Philips, A ;
Eaton, EN ;
Classon, M ;
Geng, Y ;
Sardet, C .
EMBO JOURNAL, 1999, 18 (07) :1878-1890
[40]  
MAW MA, 1992, CANCER RES, V52, P3094